Poster
Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST): Efficacy and Safety Data From Phase 3 VOYAGER Study
Author
Yoon-Koo Kang
Condition
gastrointestinal stromal tumors
Drug target
KIT receptor, PDGFRA tyrosine kinase proto-oncogenes
Source url
s3://convoke-optic-posters/2024-05-10/Blueprint-Medicines-CTOS-2020-Avapritinib-GIST-VOYAGER-Trial-Poster.pdf
4 organizations
1 product
Product
AvapritinibOrganization
Blueprint MedicinesOrganization
Sarcoma Center, Dana Farber Cancer InstituteOrganization
MD Anderson Cancer Center